title: [Effects of vitamin C on the inhibition of human leucocyte antigen class I (HLA-I) expression of human peripheral blood mononuclear cells induced by deoxynivalenol in vitro].
abstract: OBJECTIVE
  To explore the putative effects of Vitamin C (Vit C) on inhibition of human leucocyte antigen class I (HLA-I) expression of human peripheral blood mononuclear cells (HPBMCs) induced by deoxynivalenol (DON) in vitro.
  
  
  METHODS
  The effects of Vit C on the changes of HLA-I expression of HPBMCs induced by DON in vitro were evaluated with cell culture, flow cytometry (FCM), Western blotting and immunocytochemical methods.
  
  
  RESULTS
  FCM analysis showed that HLA-I expression of HPBMCs in DON treated cells was significantly lower than that in controls (FI 0.88 +/- 0.02 vs 1.00 +/- 0.03, P < 0.05). As compared with DON group, the HLA-I expressions of HPBMCs in the two Vit C (25 micromol/L and 100 micromol/L) pretreatment groups were all significantly increased (1.15 +/- 0.06 and 1.10 +/- 0.02 vs 0.88 +/- 0.02, P < 0.05). Exposure to different dosage of Vit C alone could dramatically increase the expression of HLA-I of HPBMCs in vitro as compared with that in the normal control (FI for 25 micromol/L and 100 micromol/L Vit C treatment group was 1.28 +/- 0.03 and 1.25 +/- 0.05 respectively, P < 0.05). Immunocytochemical results showed that the percentages of HLA-I positive expression of HPBMCs in Vit C pretreatment groups at different dosages were significantly higher than those in DON group (70.10 +/- 6.90)%, (64.50 +/- 5.50)% vs (42.20 +/- 4.30)%, P < 0.05. Western blotting confirmed the results of FCM and immunocytochemistry.
  
  
  CONCLUSIONS
  Vitamin C pretreatment at different dosages could reverse at some extent the inhibitive effects of DON on HLA-I expression of HPBMCs.
authors.affiliation: Laboratory of Pathology, Hebei Medcial University, Shijiazhuang 050017, China.
authors.forename: Bing-juan
authors.initials: BJ
authors.lastname: Zhou
authors.forename: Yue-hong
authors.initials: YH
authors.lastname: Li
authors.forename: Xiang-hong
authors.initials: XH
authors.lastname: Zhang
authors.forename: Ling-xiao
authors.initials: LX
authors.lastname: Xing
authors.forename: Xia
authors.initials: X
authors.lastname: Yan
authors.forename: Jun-ling
authors.initials: JL
authors.lastname: Wang
authors.forename: Jing
authors.initials: J
authors.lastname: Liu
authors.forename: Xin
authors.initials: X
authors.lastname: Xing
mesh_terms: D001205:Ascorbic Acid / Q000494:pharmacology*; D002478:Cells, Cultured; D005434:Flow Cytometry; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D014255:Trichothecenes / Q000494:pharmacology
chemical_list: D015395:Histocompatibility Antigens Class I; D014255:Trichothecenes; C007262:deoxynivalenol; D001205:Ascorbic Acid